As for safety, 43% of patients in the crizotinib arm had a grade ≥3 adverse event, the most common of which were diarrhea, ...

Over the past 20 years, there have been dramatic advances in treatment options for people diagnosed with non-small cell lung ...

The University of Kentucky Markey Cancer Center's Graham Warren, M.D., Ph.D., and international collaborators have led a ...

A study of nearly half a million women found the risk of a secondary cancer after breast cancer was only 2 percent higher ...

University of Colorado Cancer Center member D. Ross Camidge, MD, PhD, has spent his career fighting lung cancer. In 2022, ...

Hideko Warner shared how she faced three cancers at once and became the first in Orange County to receive biology-guided radiation therapy with no side effects.

The therapy is said to have shown favourable tumour uptake and quick elimination from the bloodstream and critical organs.

Crizotinib, an approved treatment for advanced ALK-positive (ALK+) non-small cell lung cancer (NSCLC), did not improve ...

TRIAD — Novant Health is the first health system in the nation to offer an advanced form of radiation therapy that advocates say more accurately targets tumors. The therapy, called RapidArc Dynamic, ...

Here’s what you should know about updates to screening guidelines, advances in treatment and the one diet that may help ...

Dr Srivatsa Lokeshwaran highlights how CBCT is transforming early lung cancer detection and diagnosis in India ...

A multi-center, randomized phase III trial has found that a three-week hypofractionated radiotherapy (HypoRT) schedule with ...